Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-103 in Healthy Volunteers

NCT01688089 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
67
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Orion Corporation, Orion Pharma